Cytokinetics Inc
CYTK
Market Cap$4.14B
Close$
$-12.40
135.8% downside
Current Fair Value
135.8% downsideOvervalued by 135.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.14 Billion |
|---|---|
| Enterprise Value | $4.91 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5.26 |
| Beta | 0.59 |
| Outstanding Shares | 118,496,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.68 |
|---|---|
| PEG | -35.19 |
| Price to Sales | - |
| Price to Book Ratio | -11.55 |
| Enterprise Value to Revenue | 255.44 |
| Enterprise Value to EBIT | -9.18 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | -3.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cytokinetics Inc
CEO: Robert Blum